Search
for
Sort by
Research 211–240 of 1000+
- Suprabasal Desmoglein 3 Expression in the Epidermis of Transgenic Mice Results in Hyperproliferation and Abnormal Differentiation
- Increased expression of keratin 16 causes anomalies in cytoarchitecture and keratinization in transgenic mouse skin.
- Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor
- Squamous epithelial proliferation induced by walleye dermal sarcoma retrovirus cyclin in transgenic mice
- Overexpression of human keratin 16 produces a distinct skin phenotype in transgenic mouse skin
- Retinoic acid and dimethyl sulfoxide promote efficient delivery of transgenes to mouse skin by topically transdermal penetration
- Expression of the guinea-pig alpha-lactalbumin gene in transgenic mice
- Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair
- Overexpression of protein kinase C-α in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-α expression but not tumor promotion
- What Surgeons Need to Know About Gender Confirmation Surgery When Providing Care for Transgender Individuals
- Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Dynamic Gender Presentations: Understanding Transition and “De-Transition” Among Transgender Youth
- Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents
- Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- A systematic review of antiandrogens and feminization in transgender women
- The targeted overexpression of a Claudin mutant in the epidermis of transgenic mice elicits striking epidermal and hair follicle abnormalities
- Medical Options for Care of Gender Diverse and Transgender Youth
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare
- Cultural Sensitivity and Challenges in Management of the Transgender Patient With ESRD in Transplantation
- Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Necessity of facial contouring in feminization surgery for Chinese transgender females
- Framework guidelines for the process of caring for the health of adolescent transgender (T) and non-binary (NB) people experiencing gender dysphoria — the position statement of the expert panel
- A Review of Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults in South Korea
- Translucent Voices: Creating Sound Pedagogy And Safe Spaces For Transgender Singers In The Choral Rehearsal
- Is Wnt5a overexpression sufficient for generating a psoriasis‐like phenotype in transgenic mice?
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals